TITAN PHARMACEUTICALS INC 4
4 · TITAN PHARMACEUTICALS INC · Filed Mar 18, 2015
Insider Transaction Report
Form 4
TITAN PHARMACEUTICALS INCTTNP.OB
BHONSLE SUNIL
DirectorPresident
Transactions
- Award
Option to Purchase Common Stock
2015-03-16−240,000→ 240,000 totalExercise: $0.60Exp: 2025-03-16→ Common Stock (240,000 underlying)
Footnotes (1)
- [F1]50% of the options have vested on the grant date and the balance shall vest on the first anniversary of the grant date